Pages that link to "Q34451365"
Jump to navigation
Jump to search
The following pages link to Histotype-specific copy-number alterations in ovarian cancer (Q34451365):
Displaying 24 items.
- Genetic and epigenetic heterogeneity of epithelial ovarian cancer and the clinical implications for molecular targeted therapy (Q26769604) (← links)
- Potential targets for ovarian clear cell carcinoma: a review of updates and future perspectives (Q26775315) (← links)
- Aberrant DNA damage response pathways may predict the outcome of platinum chemotherapy in ovarian cancer (Q28543351) (← links)
- An integrative approach identified genes associated with drug response in gastric cancer. (Q34465851) (← links)
- Adenocarcinoma of Mullerian origin: review of pathogenesis, molecular biology, and emerging treatment paradigms. (Q34528553) (← links)
- HER2 amplification and clinicopathological characteristics in a large Asian cohort of rare mucinous ovarian cancer (Q34688984) (← links)
- Optimizing Ventana chromogenic dual in-situ hybridization for mucinous epithelial ovarian cancer (Q35076986) (← links)
- Integrated copy number and expression analysis identifies profiles of whole-arm chromosomal alterations and subgroups with favorable outcome in ovarian clear cell carcinomas (Q35652910) (← links)
- In vivo tumor growth of high-grade serous ovarian cancer cell lines (Q35927115) (← links)
- GRHL2-miR-200-ZEB1 maintains the epithelial status of ovarian cancer through transcriptional regulation and histone modification. (Q36591554) (← links)
- WWOX CNV-67048 Functions as a Risk Factor for Epithelial Ovarian Cancer in Chinese Women by Negatively Interacting with Oral Contraceptive Use. (Q36829194) (← links)
- Expression signature distinguishing two tumour transcriptome classes associated with progression-free survival among rare histological types of epithelial ovarian cancer (Q37174032) (← links)
- Genome-wide DNA copy number analysis in clonally expanded human ovarian cancer cells with distinct invasive/migratory capacities (Q37716509) (← links)
- Genomic alterations as mediators of miRNA dysregulation in ovarian cancer. (Q38256465) (← links)
- An integrative approach to assess X-chromosome inactivation using allele-specific expression with applications to epithelial ovarian cancer. (Q46357857) (← links)
- CAISMOV24, a new human low-grade serous ovarian carcinoma cell line. (Q47581360) (← links)
- Identifying disease-associated copy number variations by a doubly penalized regression model (Q89077811) (← links)
- Molecular signatures of X chromosome inactivation and associations with clinical outcomes in epithelial ovarian cancer (Q90700273) (← links)
- Two types of primary mucinous ovarian tumors can be distinguished based on their origin (Q91152086) (← links)
- A meta-analysis of multiple matched aCGH/expression cancer datasets reveals regulatory relationships and pathway enrichment of potential oncogenes (Q92121461) (← links)
- Genome-wide DNA copy number profiling and bioinformatics analysis of ovarian cancer reveals key genes and pathways associated with distinct invasive/migratory capabilities (Q92374402) (← links)
- Pan-Cancer and Single-Cell Modeling of Genomic Alterations Through Gene Expression (Q92405554) (← links)
- Integrated Genomic, Epigenomic, and Expression Analyses of Ovarian Cancer Cell Lines (Q93372382) (← links)
- Integrative genomics approach identifies molecular features associated with early-stage ovarian carcinoma histotypes (Q94686779) (← links)